4886

JP:CO:ASKA-PHARMA-HD

あすか製薬ホールディングス株式会社

  • Stock

Last Close

2,036.00

22/11 06:45

Market Cap

67.99B

Beta: -

Volume Today

28.50K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
net income
495M
-
1.19B
141.01%
701M
41.24%
2.94B
319.97%
2.39B
18.89%
1.74B
26.97%
649M
62.79%
2.71B
318.03%
6.16B
127.17%
5.36B
13.08%
7.54B
40.84%
depreciation and amortization
2.46B
-
1.81B
26.19%
2.06B
13.33%
2.50B
21.58%
2.39B
4.28%
2.62B
9.36%
3.76B
43.66%
3.36B
10.61%
2.88B
14.19%
3.13B
8.39%
2.66B
14.87%
deferred income tax
stock based compensation
change in working capital
2.17B
-
-3.19B
246.50%
166M
105.21%
-748M
550.60%
-2.10B
180.75%
-2.28B
8.38%
-5.25B
130.58%
-139M
97.35%
-3.02B
2,074.10%
-4.50B
48.97%
-6.21B
37.92%
accounts receivables
1.84B
-
-1.04B
156.70%
-83M
92.03%
-919M
1,007.23%
-915M
0.44%
-622M
32.02%
-8.47B
1,262.06%
639M
107.54%
-1.36B
312.99%
-742M
45.48%
-370M
50.13%
inventory
338M
-
-2.14B
734.32%
249M
111.61%
171M
31.33%
-1.19B
792.98%
-2.14B
80.34%
2.21B
203.65%
-330M
114.90%
-687M
108.18%
-2.63B
282.39%
-2.71B
3.27%
accounts payables
1.89B
-
-1.06B
156.01%
392M
137.09%
412M
5.10%
-980M
337.86%
1.49B
252.45%
other working capital
-1.40B
-
2.07B
247.15%
-840M
140.66%
-1.39B
65%
-153M
88.96%
-4.62B
2,919.61%
other non cash items
-2.51B
-
5.89B
334.36%
-4.27B
172.58%
7.37B
272.38%
-2.61B
135.38%
418M
116.04%
346M
17.22%
605M
74.86%
-3.18B
626.28%
-631M
80.18%
4.40B
797.46%
net cash provided by operating activities
2.62B
-
5.71B
118.27%
-1.35B
123.63%
12.06B
994.22%
76M
99.37%
2.50B
3,194.74%
-492M
119.65%
6.54B
1,429.47%
2.84B
56.55%
3.35B
17.91%
1.49B
55.66%
investments in property plant and equipment
-1.82B
-
-1.95B
6.99%
-2.30B
18.10%
-690M
69.96%
-744M
7.83%
-15.72B
2,013.31%
-2.26B
85.60%
-1.10B
51.24%
-2.38B
115.31%
-746M
68.62%
-1.45B
94.77%
acquisitions net
-2M
-
-2.34B
-
-53M
97.74%
-285M
437.74%
-1.46B
413.68%
purchases of investments
-599M
-
-65M
89.15%
-1M
98.46%
-56M
5,500%
-400M
614.29%
-852M
113.00%
sales maturities of investments
1.65B
-
599M
-
11M
98.16%
190M
1,627.27%
4.63B
2,336.84%
other investing activites
-483M
-
48M
109.94%
-4.48B
9,431.25%
312M
106.97%
-2.60B
934.62%
-104M
96.01%
-598M
475%
-18M
96.99%
9.22B
51,311.11%
115M
98.75%
845M
634.78%
net cash used for investing activites
-2.30B
-
-1.90B
17.56%
-6.78B
257.20%
-378M
94.42%
-3.35B
785.71%
-14.78B
341.46%
-2.93B
80.20%
-2.87B
2.08%
6.74B
335.28%
-1.13B
116.70%
1.71B
251.51%
debt repayment
-13.52B
-
-48M
99.64%
-23M
52.08%
-2.30B
9,891.30%
-1.42B
38.08%
-3.14B
120.52%
common stock issued
4M
-
54M
1,250%
52M
3.70%
248M
376.92%
1.37B
451.61%
9M
99.34%
common stock repurchased
38M
-
23M
39.47%
60M
160.87%
13M
78.33%
-2M
-
54M
2,800%
52M
3.70%
-248M
576.92%
55M
122.18%
9M
83.64%
dividends paid
-388M
-
-389M
0.26%
-389M
0%
-390M
0.26%
-392M
0.51%
-395M
0.77%
-398M
0.76%
-484M
21.61%
-398M
17.77%
-452M
13.57%
-792M
75.22%
other financing activites
-224M
-
-191M
14.73%
4.34B
2,373.30%
-2.01B
146.22%
-750M
62.63%
-90M
88%
-54M
40%
-52M
3.70%
-300M
476.92%
-1.37B
356%
-22M
98.39%
net cash used provided by financing activities
-574M
-
-557M
2.96%
4.01B
820.47%
-2.38B
159.41%
-1.14B
52.10%
13.04B
1,241.51%
-392M
103.01%
-455M
16.07%
-3.00B
558.46%
-1.82B
39.25%
-3.94B
116.65%
effect of forex changes on cash
1M
-
-2M
300%
-2M
-
-15M
650%
net change in cash
-259M
-
3.26B
1,357.14%
-4.11B
226.29%
9.30B
326.19%
-4.41B
147.46%
761M
117.24%
-3.81B
601.05%
3.22B
184.45%
6.59B
104.63%
402M
93.90%
-3.77B
1,037.06%
cash at beginning of period
10.35B
-
11.11B
7.36%
7.29B
34.33%
10.51B
44.15%
17.10B
62.67%
17.50B
2.35%
cash at end of period
-259M
-
3.26B
1,357.14%
-4.11B
226.29%
9.30B
326.19%
-4.41B
147.46%
11.11B
351.63%
7.29B
34.33%
10.51B
44.15%
17.10B
62.67%
17.50B
2.35%
13.74B
21.52%
operating cash flow
2.62B
-
5.71B
118.27%
-1.35B
123.63%
12.06B
994.22%
76M
99.37%
2.50B
3,194.74%
-492M
119.65%
6.54B
1,429.47%
2.84B
56.55%
3.35B
17.91%
1.49B
55.66%
capital expenditure
-1.82B
-
-1.95B
6.99%
-2.30B
18.10%
-690M
69.96%
-744M
7.83%
-15.72B
2,013.31%
-2.26B
85.60%
-1.10B
51.24%
-2.38B
115.31%
-746M
68.62%
-1.45B
94.77%
free cash flow
798M
-
3.77B
371.80%
-3.65B
196.84%
11.37B
411.93%
-668M
105.87%
-13.22B
1,878.89%
-2.76B
79.15%
5.44B
297.28%
465M
91.45%
2.60B
460.22%
33M
98.73%

All numbers in (except ratios and percentages)